Protara Therapeutics, Inc. - Common Stock —— 季度财务数据 (NASDAQ:TARA) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -9.31 M-14.71 M-12.25 M-12.45 M-16.95 M-21.34 M -62.99 M 投资活动产生的现金 22.5 M-58.35 M-47.72 M-6.51 M-26.91 M-14.72 M -95.86 M 融资活动产生的现金 97.85 M1.73 M8 00013 K80.96 M1.14 M 82.13 M 自由现金流 -9.31 M-14.71 M-12.25 M-12.45 M-16.95 M-21.34 M -62.99 M

新闻

Protara Therapeutics, Inc. (TARA) Discusses Interim Safety and Durability Data From STARBORN-1 Trial of TARA-002 in Lymphatic Malformations - Slideshow (NASDAQ:TARA) 2026-05-20

Protara Therapeutics, Inc. (TARA) Discusses Interim Safety and Durability Data From STARBORN-1 Trial of TARA-002 in Lymphatic Malformations Transcript

TD Cowen维持Protara Therapeutics股票评级,基于试验数据

TD Cowen reiterates Protara Therapeutics stock rating on trial data

摩根大通首次覆盖Protara Therapeutics股票,给予增持评级

摩根大通首次覆盖Protera Therapeutics股票,评级为增持

JPMorgan initiates Protera Therapeutics stock at Overweight

Protara Therapeutics, Inc. (TARA) Presents at 2026 ASCO Genitourinary Cancers Symposium - Slideshow (NASDAQ:TARA) 2026-02-26

AMD and Keysight Technologies among market cap stock movers on Tuesday

AMD, IBM among market cap stock movers on Tuesday

What's Going On With Protara Therapeutics Stock Tuesday? - Protara Therapeutics (NASDAQ:TARA)

Protara Therapeutics股价因试验数据发布而暴跌